Dengue virus
| Ivermectin | DENV | Importin ?/?-mediated nuclear import inhibitor | Phase 3 | — | Human importin | |
| ABMA | DENV | Prevents endosomal fusion/maturation | Preclinical | — | Human GTPase | |
| Amantadine | DENV | Viroporin inhibitor; blocks viral ion channel activity | Approved (other) | Japan | Viral ion channel (viroporin) | |
| Brequinar | DENV | DHODH (DHODH) inhibitor | Preclinical | — | Human DHODH | |
| Chloroquine | DENV | Antimalaria agent; chemo/radio sensitizer | Phase 2 | — | Human (multiple) | |
| Labyrinthopeptin A1 | DENV | Interference with viral phospholipid membrane | Preclinical | — | Viral membrane | |
| Labyrinthopeptin A2 | DENV | viral membrane lipid phosphatidylethanolamine | Preclinical | — | Viral membrane | |
| Nitroprusside | DENV | Nitrix oxide donor | Preclinical | — | Human NPR1 |